Abstract:Introduction: Regulatory T cells (Treg) have been shown to prevent allograft rejection and plays an important role in promote donorspecific antigenic tolerance in solid organ transplantation. In this study, we analyzed the ratio of CD4+CD25+Foxp3+/Th17 T cell in the peripheral blood of kidney recipients with living-related donor in different immunosuppressive therapy, and analyzed the relationship between the ratio of CD4+CD25+Foxp3+/Th17 T cell and patients who have long-term survival. Methods: The study was approved by the local ethical committee. Twelve renal transplant recipients with living-related donor received combined donor-specific blood transfusion and kidney transplantation more than six years were enrolled, and ten healthy volunteers as healthy control (HC). Posttransplant patients were divided into two groups depending on their immunosuppressive therapy: calcineurin inhibitors (CNI) and rapamycin (Rapa). Analyzed the expression of CD4+CD25+Foxp3+T cells and Th17 T cells in the peripheral blood under the stimulate condition (phorbol myfismte acetate and ionomycin) and no-stimulate condition for all objects by flow cytometry, and the mixed lymphocyte reaction (MLR) in recipient with their donors and independent third party by methyl thiazolyl tetrazolium (MTT). Results: The proportion of CD4+CD25+Foxp3+ T cells in the peripheral blood under the stimulate condition and no-stimulate condition in group of Rapa were 2.24% and 2.14%, respectively, significant higher than group of CNI (P< 0.05, Table 1), and, there was no significant difference for the proportion of Th17 T cells between the group of Rapa and CNI. The ratio of CD4+CD25+Foxp3+/Th17 T cells in group of Rapa under the stimulate condition and no-stimulate condition were 3.42 and 8.92, respectively, significant higher than group of CNI (P< 0.05, Table 1). In all groups, the result of MLR with independent third party higher than their donors, and the MLR with independent third party in group of Rapa was higher than group of CNI.[Table 1 The expression of Treg and Th17 T cells]Conclusion: This study showed in living-related donor kidney recipients who received combined donor-specific blood transfusion and kidney transplantation obtain better long-term graft and patient survival. Increased numbers of CD4+CD25+Foxp3+ T cells and the ratio of CD4+CD25+Foxp3+/Th17 T cells and higher MLR with independent third party in group of Rapa compared with group of CNI. Therefore, monitoring of Treg in the peripheral blood as a biomarker of tolerance may detect unresponsiveness to the graft.

Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation

Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Mtor Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury.

Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Rapamycin promotes the expansion of CD4(+) Foxp3(+) regulatory T cells after liver transplantation.

Conversion from Calcineurin Inhibitors to Mammalian Target-of-Rapamycin Inhibitors in Heart Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials.

Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation.

The Effects of Rapamycin on Regulatory T Cells: Its Potential Time-Dependent Role in Inducing Transplant Tolerance.

Effects of Immunosuppressants on CD+ CD25+ Regulatory T Cells in Human Renal Transplant Recipients

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation

RapaLink-1 Outperforms Rapamycin in Alleviating Allogeneic Graft Rejection by Inhibiting the Mtorc1-4E-bp1 Pathway in Mice.

Immunomodulation of T Cell-Mediated Alloimmunity by Proximity to Endothelial Cells under the Mammalian Target of Rapamycin Blockade.

Comparative Safety and Efficacy of Immunosuppressive Regimens Post-kidney Transplant: A Systematic Review

The Mixed Lymphocyte Reaction and the Ratio of Cd4(+)Cd25(+)Foxp3(+)/Th17 T Cell in Long Term Graft and Recipents Survival of Kidney Transplantation with Living-Related Donor

The Role of Mtor Inhibitors in Liver Transplantation: Reviewing the Evidence

The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta-analysis

Deep phenotyping of T cell populations under long-term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry

Safety and efficacy of conversion from calcineurin inhibitors to mammalian-target-of-rapamycin inhibitors in liver transplant recipients: a meta-analysis of randomized controlled trials

Limited Efficacy of Rapamycin Monotherapy in Vascularized Composite Allotransplantation.